Recursion

SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today launched…

SALT LAKE CITY, TORONTO et MONTRÉAL, 13 juill. 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), société biotechnologique au stade clinique chef de file dans le décodage biologique pour…

SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), ein führendes, im klinischen Stadium tätiges TechBio-Unternehmen, das die Biologie…

SALT LAKE CITY y TORONTO y MONTREAL, July 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), una empresa líder de biotecnología en etapa clínica con la decodificación de biología para…

साल्ट लेक सिटी, टोरंटो और मॉन्ट्रियल, July 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), औषधि खोज को औद्योगिक बनानेवाली एक अग्रणी क्लिनिकल स्टेज TechBio कंपनी ने, आज NVIDIA…

SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug…

A man wearing a mask walks past a Nvidia logo in Taipei, Taiwan.Sopa Images | Lightrocket | Getty ImagesChipmaker Nvidia will invest $50 million in Recursion Pharmaceuticals to speed up the…